| 000 | 01057 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517064335.0 | ||
| 264 | 0 | _c20160111 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a0927-3042 | ||
| 024 | 7 |
_a10.1007/978-3-319-22539-5_9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCallahan, Margaret K | |
| 245 | 0 | 0 |
_aCheckpoint Blockade for the Treatment of Advanced Melanoma. _h[electronic resource] |
| 260 |
_bCancer treatment and research _c2016 |
||
| 300 |
_a231-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies _xtherapeutic use |
| 650 | 0 | 4 |
_aCTLA-4 Antigen _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
| 700 | 1 | _aFlaherty, Catherine R | |
| 700 | 1 | _aPostow, Michael A | |
| 773 | 0 |
_tCancer treatment and research _gvol. 167 _gp. 231-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-319-22539-5_9 _zAvailable from publisher's website |
| 999 |
_c25480626 _d25480626 |
||